New Tuberculosis Diagnostic Method for Ukraine
Ukraine will implement a new diagnostic method for tuberculosis starting in April 2026, phasing out the traditional Mantoux test. A more precise interferon-gamma release assay (IGRA) will be used nationwide to detect the disease. This announcement was made by Volodymyr Kurpita, Director General of the Public Health Center, during an event marking World Tuberculosis Day. This shift aligns Ukraine with diagnostic practices common in many Western countries.
Reforms in Treatment and Prevention
Alongside diagnostic changes, Ukraine has also enacted significant reforms in tuberculosis treatment. The standard therapy course has been shortened to six to nine months, down from the previous eighteen-month regimen. This innovation aims to increase treatment efficacy and make the process easier for patients. As a result of these changes, the patient recovery rate in Ukraine has risen to 75%. Notably, 70% of patients now receive outpatient treatment, simplifying access to medical care.
Tuberculosis prevention in Ukraine begins on a child's first day of life with mandatory vaccination. These steps demonstrate the state's efforts to combat tuberculosis, aimed at improving public health and reducing incidence. The introduction of new diagnostic and treatment methods is a crucial step in this fight.
The implementation of modern methods for diagnosing and treating tuberculosis in Ukraine reflects progress in the healthcare sector and a commitment to improving the quality of medical services. — Volodymyr Kurpita
Reducing treatment duration and increasing the accessibility of medical aid are key elements for improving the overall health of the population. These changes could significantly impact the reduction of tuberculosis morbidity and mortality in Ukraine, an important aspect in the global fight against this disease.